US$ 29.01
bpc 157 and breastfeeding What are the considerations potential risks for a patient with a history of cancer, pregnancy, or considering BPC157 (Body Protection Compound 157) peptide therapy for muscle and tendon injuries or BPC-157 Peptide and Lyme Disease:
Description
Intermediates of alpha-synuclein aggregation: Implications in Parkinsons disease pathogenesis

The compounds selective mechanism and lack of off-target effects support its safety profile

G., Zhu X

2006;12:BR146153
